From Hell To Veins

May 12, 2010

Population Reduction And Recent Vaccine Patents

My Commentary:
Below is Dr. True Ott’s investigation into U.S.,and perhaps, international patents of H1N1 lab created virus structures by Baxter et al. This ‘claim’ is no great revelation to this blog and for those who follow it.

For those who do NOT want to do ANY research into these FACTS but, simply want to bury their heads in the sand by saying the ‘sleep trigger’ phrase, ‘CONSPIRACY THEORY’. I’ve got some real bad news for you. Your denial will NOT save you from these mad creatures running the planet right now.

Here’s something to think about. Recently Pfizer in a law suit ADMITTED (as if no big deal) that the pharmaceutical industry is hard at work making these genetically modified DNA / RNA viral structures here in the USA. Unfortunately for Pfiser, the rest of the world STILL believes these viruses need to be created in at least a ‘level 4’ bio hazard lab.

Dr. True Ott in studying the Novartis flu mist patent stumbled upon one of the key FACTS in regards to the population reduction plan as outlined at the Club of Rome. Dr. Ott does NOT even know what he stumbled upon. I have been trying to make this point as clear as I can, yet, even when someone doing ‘GREAT’ research on this has a MAJOR key to the plan right in the palm of their hand, they can NOT see what I have been trying to get across to the public all along. The lab virus bioweapons, that are being used are STRICTLY designed to have a ‘limited’ kill ratio. I will NOT stop repeating this, those who have been planning the population reduction operation CAN IN NO WAY AFFORD A WILD FIRE PANDEMIC (their words). These designer viral structures DO HAVE, either a self-destruct mechanism built into them OR, they will have a viral structure which will limit the next viral mutation(s). At least that was the way it was explained. The reason for all of this, is that these bioweapon viruses are being designed to kill ONLY enough people to ‘scare’ the rest of the population into ACCEPTING A MANDATORY VACCINE POLICY. The up coming mandatory vaccine program IS THE POPULATION REDUCTION PROGRAM. The entire health care system NOW put in place was put in place for one purpose only, POPULATION REDUCTION. This is where the ‘system’ needed to facilitate A CONTROLLED population operation will take place. Where the overseers can CHOOSE WHO LIVES AND WHO DIES, and control the entire operation just like a video war game. (their words) Also, the very reason why influenza viruses were chosen for the man made pandemic operation was that once mandatory vaccines were accepted the vaccines would be for something that would need to be taken ‘annually’ and NOT as a one time deal.

Now, I have been trying to get this message through the thickest of heads and finally Bill Gates said the exact same thing. That, population reduction WILL occur through the (new) health care system AND vaccines.

Now, with all that said, will these lab viruses spiral out of control? I can’t say they will not. However, I DO KNOW the people responsible for these viral projects think they can control the outbreaks.

Special thanks to Labvirus.com
VIDEO Virus And Vaccine Patented By Baxter Since ’07

VIEW THE PATENT APPLICATIONS HERE:
Patent Application for H1N1 Virus: US20080069821A1
Patent Application Link
http://www.google.com/patents?id=EGSoAAAAEBAJ&zoom=4&pg=PA1#v=onepage&q&f=false
Related US Patent #5,698,433 (1997 version):
METHOD FOR PRODUCING INFLUENZA VIRUS AND VACCINE (assignee: Baxter)

What is claimed is:
1. An isolated polypeptide, wherein said polypeptide is selected from the group consisting of: a) a polypeptide comprising the amino acid sequence encoded by the nucleotide sequence as shown in any one of SEQ ID NOS:21-26 or 33-38 or 45; b) a polypeptide comprising the amino acid sequence as shown in any one of SEQ ID NOS:27-32 or 39-44; c) the mature form of a polypeptide comprising the amino acid sequence as shown in any one of SEQ ID NOS: 27-32 or 39-44; d) a polypeptide comprising an amino acid sequence encoded by a polynucleotide which hybridizes under highly stringent conditions to a polynucleotide comprising a nucleotide sequence encoding (a) (b) or (c); and e) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the polypeptide of (b).

2. An immunogenic composition comprising an immunologically effective amount of at least one polypeptide of claim 1.

3. An isolated antibody that specifically binds the polypeptide of claim 1.

4. A method for stimulating the immune system of an individual to produce a protective immune response against influenza virus, the method comprising administering to the individual an immunologically effective amount of the polypeptide of claim 1 in a physiologically acceptable carrier.

5. A recombinant influenza virus comprising the polypeptide of claim 1.

6. An immunogenic composition comprising an immunologically effective amount of the recombinant influenza virus of claim 5.

7. A method for stimulating the immune system of an individual to produce a protective immune response against influenza virus, the method comprising administering to the individual an immunologically effective amount of the recombinant influenza virus of claim 5 in a physiologically acceptable carrier.

8. An isolated polynucleotide, wherein said polynucleotide is selected from the group consisting of: a) a polynucleotide comprising the nucleotide sequence as shown in any one of SEQ ID NOS: 21-26 or 33-38 or 45, or a complementary sequence thereof; b) a polynucleotide comprising a nucleotide sequence encoding a polypeptide comprising the amino acid sequence as shown in any one of SEQ ID NOS: 27-32 or 39-44, or a complementary nucleotide sequence thereof; c) a polynucleotide which hybridizes under highly stringent conditions over substantially the entire length of the polynucleotide of (a); and d) a polynucleotide comprising a nucleotide sequence having at least 98% sequence identity to the polynucleotide of (a).

9. An immunogenic composition comprising at least one polynucleotide of claim 8.

10. A cell comprising at least one polynucleotide of claim 8.

11. A vector comprising the polynucleotide of claim 8.

12. The vector of claim 11, wherein the vector is a plasmid, a cosmid, a phage, a virus, or a fragment of a virus.

13. The vector of claim 12, wherein the vector is an expression vector.

14. A cell comprising the vector of claim 13.

15. An influenza virus comprising one or more polynucleotides of claim 8.

16. The virus of claim 15, wherein the virus is a reassortant virus.

17. A 6:2 reassortant influenza virus, wherein said virus comprises 6 internal genome segments from A/Ann Arbor/6/60 and 2 genome segments that encode an HA and/or a NA polypeptide selected from the group consisting of: the polypeptides of SEQ ID NOS:27-32, and 39-44.

18. A method of producing a reassortant influenza virus, the method comprising: culturing the cell of claim 14 in a suitable culture medium under conditions permitting expression of said polynucleotide; and, isolating the reassortant influenza virus from a cell population comprising said cell or the medium.

19. An immunogenic composition comprising an immunologically effective amount of the reassortant influenza virus of claim 17.

There are 19 more claims which cannot fit into this description. Please check the first link above for the rest.

Leave a Comment »

No comments yet.

RSS feed for comments on this post. TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Blog at WordPress.com.

%d bloggers like this: